|
PHusis Therapeutics is focused on targeting the PH Domain (pleckstrin homology domain) of proteins that are critical in many therapeutic applications including cancer, inflammation, cardiovascular and neurological diseases and diabetes. The PH domain is known to regulate protein signaling and its inhibition with small molecules that bind specifically to this portion of the protein, provides a novel approach to disease modulation.
|
